Masimo Corp specializes in advanced patient monitoring technologies, offering a wide range of products that improve the accuracy of vital signs measurement. Its innovative solutions, such as the Masimo SET for pulse oximetry and the rainbow SET platform for noninvasive monitoring of various blood constituents, cater to hospitals, emergency services, and home care settings. Beyond monitoring, Masimo also develops hospital automation and telehealth solutions, enhancing patient care and safety. Founded in 1989 and based in Irvine, California, Masimo continues to lead in medical technology, serving healthcare providers and consumers globally.
Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, and, as we mentioned before, it all depends on the status of the war with Iran and…
Danaher (NYSE: DHR | DHR Price Prediction) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share. The transaction, announced…
A solid outlook from the world's largest chip foundry boosted tech stocks on Thursday. Apple and Berkshire Hathaway were also in the news.
Another acquisition for Bristol Myers, another acquisition offer from Nano Dimension, and Apple's Watch woes.
Apple is removing some Watch models ahead of an expected ban on future sales, and opponents line up against U.S. Steel acquisition.
